These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37794598)

  • 1. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes.
    Randi BA; Higashino HR; Silva VPD; Xavier EM; Rocha V; Costa SF
    Rev Med Virol; 2023 Nov; 33(6):e2483. PubMed ID: 37794598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
    Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
    Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
    Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
    Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
    Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Cohort Study.
    Bhatt NS; Sharma A; St Martin A; Abid MB; Brown VI; Diaz Perez MA; Frangoul H; Gadalla SM; Herr MM; Krem MM; Lazarus HM; Martens MJ; Mehta PA; Nishihori T; Prestidge T; Pulsipher MA; Rangarajan HG; Williams KM; Winestone LE; Yin DE; Riches ML; Dandoy CE; Auletta JJ
    Transplant Cell Ther; 2022 Oct; 28(10):696.e1-696.e7. PubMed ID: 35798233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Mittal A; Solera JT; Ferreira VH; Kothari S; Kimura M; Pasic I; Mattsson JI; Humar A; Kulasingam V; Ierullo M; Kumar D; Hosseini-Moghaddam SM
    Transplant Cell Ther; 2023 Nov; 29(11):706.e1-706.e7. PubMed ID: 37582470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of SARS-CoV-2 in Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Recipients.
    Mushtaq MU; Shahzad M; Chaudhary SG; Luder M; Ahmed N; Abdelhakim H; Bansal R; Balusu R; DeJarnette S; Divine C; Kribs R; Shune L; Singh AK; Ganguly S; Abhyankar SH; McGuirk JP
    Transplant Cell Ther; 2021 Sep; 27(9):796.e1-796.e7. PubMed ID: 34256172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
    Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
    J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of cytomegalovirus infection and cytomegalovirus serostatus with invasive fungal infections in allogeneic haematopoietic stem cell transplant recipients: a systematic review and meta-analysis.
    Chuleerarux N; Nematollahi S; Thongkam A; Dioverti MV; Manothummetha K; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
    Clin Microbiol Infect; 2022 Mar; 28(3):332-344. PubMed ID: 34752926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
    Piñana JL; López-Corral L; Martino R; Montoro J; Vazquez L; Pérez A; Martin-Martin G; Facal-Malvar A; Ferrer E; Pascual MJ; Sanz-Linares G; Gago B; Sanchez-Salinas A; Villalon L; Conesa-Garcia V; Olave MT; López-Jimenez J; Marcos-Corrales S; García-Blázquez M; Garcia-Gutiérrez V; Hernández-Rivas JÁ; Saus A; Espigado I; Alonso C; Hernani R; Solano C; Ferrer-Lores B; Guerreiro M; Ruiz-García M; Muñoz-Bellido JL; Navarro D; Cedillo A; Sureda A;
    Am J Hematol; 2022 Jan; 97(1):30-42. PubMed ID: 34695229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three doses of a recombinant conjugated SARS-CoV-2 vaccine early after allogeneic hematopoietic stem cell transplantation: predicting indicators of a high serologic response-a prospective, single-arm study.
    Barkhordar M; Chahardouli B; Biglari A; Ahmadvand M; Bahri T; Alaeddini F; Sharifi Aliabadi L; Noorani SS; Bagheri Amiri F; Biglari M; Shemshadi MR; Ghavamzadeh A; Vaezi M
    Front Immunol; 2023; 14():1169666. PubMed ID: 37153556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.
    Karataş A; Malkan ÜY; Velet M; Demiroğlu H; Büyükaşık Y; Telli Dizman G; Inkaya AÇ; Erdoğdu B; Çınar OE; Aladağ E; Aksu S; Haznedaroğlu İC; Özcebe O; Sayınalp N; Göker H
    Turk J Med Sci; 2021 Aug; 51(4):1647-1652. PubMed ID: 33878857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 monoclonal antibodies on outcomes of COVID-19 infection in hematopoietic stem cell transplant and chimeric antigen receptor therapy recipients.
    Hahn EH; Li H; Sauter CS; Mossad SB
    Transpl Infect Dis; 2024 Aug; 26(4):e14322. PubMed ID: 38937864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplant recipients and parasitic diseases: A review of the literature of clinical cases and perspectives to screen and follow-up active and latent chronic infections.
    Fabiani S; Fortunato S; Petrini M; Bruschi F
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28128496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
    Busca A; Salmanton-García J; Marchesi F; Farina F; Seval GC; Van Doesum J; De Jonge N; Bahr NC; Maertens J; Meletiadis J; Fracchiolla NS; Weinbergerová B; Verga L; Ráčil Z; Jiménez M; Glenthøj A; Blennow O; Tanase AD; Schönlein M; Prezioso L; Khanna N; Duarte RF; Žák P; Nucci M; Machado M; Kulasekararaj A; Espigado I; De Kort E; Ribera-Santa Susana JM; Marchetti M; Magliano G; Falces-Romero I; Ilhan O; Ammatuna E; Zompi S; Tsirigotis P; Antoniadou A; Zambrotta GPM; Nordlander A; Karlsson LK; Hanakova M; Dragonetti G; Cabirta A; Berg Venemyr C; Gräfe S; Van Praet J; Tragiannidis A; Petzer V; López-García A; Itri F; Groh A; Gavriilaki E; Dargenio M; Rahimli L; Cornely OA; Pagano L
    Front Immunol; 2023; 14():1125030. PubMed ID: 36911708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
    Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
    Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group.
    Bozkurt C; Hazar V; Malbora B; Küpesiz A; Aygüneş U; Fışgın T; Karakükçü M; Kuşkonmaz B; Kılıç SÇ; Bayırlı D; Arman Bilir Ö; Yalçın K; Gözmen S; Uygun V; Elli M; Sarbay H; Küpesiz FT; Şaşmaz Hİ; Aksoy BA; Yılmaz E; Okur FV; Tekkeşin F; Yenigürbüz FD; Özek G; Atay AA; Bozkaya İO; Çelen S; Öztürkmen S; Güneş AM; Gürsel O; Güler E; Özcan A; Çetinkaya DU; Aydoğdu S; Özbek NY; Karasu G; Sezgin G; Doğru Ö; Albayrak D; Öztürk G; Aksoylar S; Daloğlu H; Odaman Al I; Evim MS; Akbayram S; Öncül Y; Zengin E; Albayrak C; Timur Ç; Kar YD; Çakmaklı HF; Tüfekçi Ö; Töret E; Antmen B
    Pediatr Transplant; 2024 May; 28(3):e14758. PubMed ID: 38659218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronavirus disease 2019 in immunocompromised patients: a comprehensive review of coronavirus disease 2019 in hematopoietic stem cell recipients.
    Lafarge A; Mabrouki A; Yvin E; Bredin S; Binois Y; Clere-Jehl R; Azoulay E
    Curr Opin Crit Care; 2022 Feb; 28(1):83-89. PubMed ID: 34813523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
    Piñana JL; Martino R; Vazquez L; López-Corral L; Pérez A; Chorão P; Avendaño-Pita A; Pascual MJ; Sánchez-Salinas A; Sanz-Linares G; Olave MT; Arroyo I; Tormo M; Villalon L; Conesa-Garcia V; Gago B; Terol MJ; Villalba M; Garcia-Gutierrez V; Cabero A; Hernández-Rivas JÁ; Ferrer E; García-Cadenas I; Teruel A; Navarro D; Cedillo Á; Sureda A; Solano C;
    Bone Marrow Transplant; 2023 May; 58(5):567-580. PubMed ID: 36854892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.